ArticleCureus2025
Hyperammonemia in Inherited Metabolic Diseases: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neonatal hyperammonemia is a medical emergency where diagnostic delay can lead to catastrophic neurological outcomes. This case report of a full-term male infant with ornithine transcarbamylase (OTC) deficiency highlights the critical challenges in its early recognition and management. The initial presentation of inborn errors of metabolism is often nonspecific in the neonatal period, and while biochemical testing is essential, it is not always rapidly available. Our experience underscores that a high index of clinical suspicion is paramount. Furthermore, this case reinforces the urgent need to expand newborn screening programs to facilitate a prompt diagnosis, allowing for the immediate initiation of treatment. Such measures are vital to prevent the irreversible pathological processes that lead to severe disability or increased mortality in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.